The results demonstrated that the Hsp90/PI3K dual inhibitor efficiently induced melanoma cell apoptotic death by interfering with the Hsp90-EGFR interaction and suppressed the downstream MAPK signaling pathways. This evidence concerns the gene HSP90AA1 and melanoma.